Literature DB >> 32427593

Psychosocial therapies in severe mental illness: update on evidence and recommendations.

Uta Gühne1, Stefan Weinmann2, Steffi G Riedel-Heller1, Thomas Becker3.   

Abstract

PURPOSE OF REVIEW: To provide an overview of the update of the evidence-based and consensus-based German S3 guideline on psychosocial therapies for severe mental illnesses (SMI), with particular attention to current developments and future research tasks. RECENT
FINDINGS: There has been a significant increase in studies on the effectiveness of psychosocial interventions in treatment of people with SMI. In the guideline a distinction is made between system-level interventions (e.g. multidisciplinary team-based psychiatric community care) and single-handed (nonteam-based) interventions (e.g. psychoeducation). Furthermore, principles of treatment (e.g. recovery-orientation) and self-help interventions (e.g. peer support) are addressed. The update of the guideline includes 33 recommendations and 12 statements. Compared with the first edition, there were upgrades in the recommendation of Supported Employment (A) and Supported Housing (A). Interventions such as peer support (B) and lifestyle interventions (A) were included for the first time. Developments are discussed in the context of most recent literature. Areas for further research are highlighted and fields for next updates such as antistigma interventions and supported parenting were identified.
SUMMARY: The present guideline offers an important opportunity to further improve health services for people with SMI. However, guideline implementation is challenging.

Entities:  

Mesh:

Year:  2020        PMID: 32427593     DOI: 10.1097/YCO.0000000000000618

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  6 in total

1.  Community-based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence.

Authors:  Helen Killaspy; Carol Harvey; Catherine Brasier; Lisa Brophy; Priscilla Ennals; Justine Fletcher; Bridget Hamilton
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

2.  [DGPPN congress 2020-Psychiatry and psychotherapy in the social environment].

Authors:  Andreas Heinz
Journal:  Nervenarzt       Date:  2020-11       Impact factor: 1.214

Review 3.  Occupational therapy interventions for adults with severe mental illness: a scoping review.

Authors:  María Rocamora-Montenegro; Laura-María Compañ-Gabucio; Manuela Garcia de la Hera
Journal:  BMJ Open       Date:  2021-10-29       Impact factor: 2.692

4.  The role of migration in mental healthcare: treatment satisfaction and utilization.

Authors:  Gabriele Gaigl; Esther Täumer; Andreas Allgöwer; Thomas Becker; Johanna Breilmann; Peter Falkai; Uta Gühne; Reinhold Kilian; Steffi G Riedel-Heller; Klemens Ajayi; Jessica Baumgärtner; Peter Brieger; Karel Frasch; Stephan Heres; Markus Jäger; Andreas Küthmann; Albert Putzhammer; Bertram Schneeweiß; Michael Schwarz; Markus Kösters; Alkomiet Hasan
Journal:  BMC Psychiatry       Date:  2022-02-15       Impact factor: 3.630

5.  Metabolic impact of a nutrition education program for the promotion of fruit and vegetable consumption with people with severe mental disorders (DIETMENT).

Authors:  Quintí Foguet-Boreu; Mireia Vilamala-Orra; Cristina Vaqué-Crusellas; Pere Roura-Poch; Montse Assens Tauste; Judit Bori Vila; Jose Manuel Santos-López; Ruben Del Río Sáez
Journal:  BMC Res Notes       Date:  2022-03-29

6.  Predictors of competitive employment in individuals with severe mental illness: results from an observational, cross-sectional study in Germany.

Authors:  Johanna Breilmann; Steffi G Riedel-Heller; Uta Gühne; Alexander Pabst; Markus Kösters; Alkomiet Hasan; Peter Falkai; Reinhold Kilian; Andreas Allgöwer; Klemens Ajayi; Jessica Baumgärtner; Peter Brieger; Karel Frasch; Stephan Heres; Markus Jäger; Andreas Küthmann; Albert Putzhammer; Bertram Schneeweiß; Michael Schwarz; Thomas Becker
Journal:  J Occup Med Toxicol       Date:  2022-01-18       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.